ACADIA Pharmaceuticals Inc (ACAD)
Current ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 938,318 | 788,284 | 728,916 | 675,296 | 616,125 | 499,170 | 492,628 | 502,850 | 507,937 | 521,552 | 532,519 | 542,223 | 617,823 | 640,917 | 645,730 | 673,984 | 717,616 | 730,213 | 735,735 | 724,421 |
| Total current liabilities | US$ in thousands | 394,870 | 343,945 | 337,851 | 330,597 | 254,254 | 209,603 | 187,942 | 224,301 | 125,630 | 116,570 | 117,681 | 119,603 | 96,068 | 88,218 | 95,328 | 109,373 | 105,967 | 91,856 | 86,422 | 99,741 |
| Current ratio | 2.38 | 2.29 | 2.16 | 2.04 | 2.42 | 2.38 | 2.62 | 2.24 | 4.04 | 4.47 | 4.53 | 4.53 | 6.43 | 7.27 | 6.77 | 6.16 | 6.77 | 7.95 | 8.51 | 7.26 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $938,318K ÷ $394,870K
= 2.38
The current ratio of ACADIA Pharmaceuticals Inc has shown a declining trend over the past few years, indicating potential liquidity challenges. From a high of 8.51 in June 2020, the current ratio has steadily decreased to 2.38 by December 2024. This downward trajectory suggests that the company may be facing difficulties in meeting its short-term obligations with its current assets. A current ratio below 2.0 typically raises red flags regarding a company's ability to cover its immediate liabilities. ACADIA Pharmaceuticals Inc should closely monitor its liquidity position and implement strategies to improve its current ratio to ensure financial stability and meet its short-term obligations effectively.
Peer comparison
Dec 31, 2024